Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,567 | -220,474 | -79,287 | -56,701 | -29,494 |
| Depreciation Amortization | 3,391 | 9,864 | 4,257 | 2,699 | 2,079 |
| Income taxes - deferred | 0 | 81,443 | -21,743 | -15,769 | -7,797 |
| Accounts receivable | -2,333 | -7,463 | -3,388 | 2,181 | 2,534 |
| Accounts payable and accrued liabilities | 1,480 | 15,820 | 6,743 | 16,966 | 5,636 |
| Other Working Capital | -7,885 | 8,308 | 5,282 | 13,408 | -1,914 |
| Other Operating Activity | 3,696 | 3,060 | 8,111 | -11,183 | -4,191 |
| Operating Cash Flow | $-50,218 | $-109,442 | $-80,025 | $-48,399 | $-33,147 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -221 | -998 | -896 | -735 | -436 |
| Purchase Of Investment | 0 | -112,379 | -110,347 | -96,300 | -43,329 |
| Sale Of Investment | 30,455 | 208,237 | 161,237 | 125,667 | 87,667 |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | 0 |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $20,234 | $94,860 | $49,994 | $28,632 | $43,902 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -776 | -1,991 | -1,351 | -834 | -409 |
| Other Financing Activity | 0 | -915 | -915 | -915 | -915 |
| Financing Cash Flow | $-776 | $-2,906 | $-2,266 | $-1,749 | $-1,324 |
| Exchange Rate Effect | -57 | 23 | 3 | 183 | 49 |
| Beginning Cash Position | 85,320 | 102,785 | 102,785 | 102,785 | 102,785 |
| End Cash Position | 54,503 | 85,320 | 70,491 | 81,452 | 112,265 |
| Net Cash Flow | $-30,817 | $-17,465 | $-32,294 | $-21,333 | $9,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,218 | -109,442 | -80,025 | -48,399 | -33,147 |
| Capital Expenditure | -221 | -998 | -896 | -735 | -436 |
| Free Cash Flow | -50,439 | -110,440 | -80,921 | -49,134 | -33,583 |